Literature DB >> 33680832

Update on functional imaging in the evaluation of diabetic foot infection.

Karthikeyan P Iyengar1, Vijay K Jain2, Muyed Kamal Awadalla Mohamed1, Raju Vaishya3, Sobhan Vinjamuri4.   

Abstract

Diabetic foot infection is a preventable complication of diabetes mellitus. It is an essential component of diabetic foot disease, which is characterised by a triad of neuropathy, ischaemia and infection. These factors may lead to foot ulceration, sepsis and amputation resulting in increased morbidity and poor quality of life. Confirming or excluding infection can be difficult especially when routine laboratory tests and plain radiographs are inconclusive. Early diagnosis and localization of diabetic foot infection is extremely important to institute timely, appropriate therapy. Structural imaging using computed tomography and magnetic resonance imaging all have individual applications towards the diagnostic workup of this condition but have their own limitations. Scintigraphic detection is based on physiochemical changes and hence provides a functional evaluation of bone pathology. We describe the evolution of functional nuclear medicine imaging including immunoscintigraphy in diabetic foot infection and highlight current applications of physiological 18-Fluoro-deoxyglucose positron emission tomography (18-FDG-PET) and computed tomography (18-FDG-PET/CT) in such patients. 18-FDG-PET/CT is a promising modality for imaging diabetic foot infection. Future studies will allow standardisation of technological details and options of 18-FDG-PET/CT interpretation in diabetic foot infection.
© 2021 The Author(s).

Entities:  

Keywords:  18F-FDG PET/CT; 18F-FDG-PET; Diabetic foot; Immunoscintigraphy; Infection imaging; Musculoskeletal infection; Osteomyelitis; PET/CT

Year:  2021        PMID: 33680832      PMCID: PMC7919944          DOI: 10.1016/j.jcot.2020.12.033

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  36 in total

Review 1.  Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET.

Authors:  Chiara Lauri; Menno Tamminga; Andor W J M Glaudemans; Luis Eduardo Juárez Orozco; Paola A Erba; Paul C Jutte; Benjamin A Lipsky; Maarten J IJzerman; Alberto Signore; Riemer H J A Slart
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

2.  Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.

Authors:  Ashu Rastogi; Anish Bhattacharya; Mahesh Prakash; Sarika Sharma; Bhagwant R Mittal; Niranjan Khandelwal; Anil Bhansali
Journal:  Nucl Med Commun       Date:  2016-12       Impact factor: 1.690

3.  Short-term predictors of amputation in patients with diabetic foot ulcers.

Authors:  Lia Ferreira; André Carvalho; Rui Carvalho
Journal:  Diabetes Metab Syndr       Date:  2018-05-17

4.  Leukoscan for orthopaedic imaging in clinical practice.

Authors:  Paul J Ryan
Journal:  Nucl Med Commun       Date:  2002-08       Impact factor: 1.690

Review 5.  Imaging modalities of the diabetic foot.

Authors:  Enzo J Sella; Dawn M Grosser
Journal:  Clin Podiatr Med Surg       Date:  2003-10       Impact factor: 1.231

6.  Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?

Authors:  Sandip Basu; Timothy Chryssikos; Mohamed Houseni; D Scot Malay; Jagruti Shah; Hongming Zhuang; Abass Alavi
Journal:  Nucl Med Commun       Date:  2007-06       Impact factor: 1.690

7.  Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot.

Authors:  Asad Nawaz; Drew A Torigian; Evan S Siegelman; Sandip Basu; Timothy Chryssikos; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2009-10-09       Impact factor: 3.488

8.  Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m-labeled monoclonal antigranulocyte antibody.

Authors:  Christopher J Palestro; Russell Caprioli; Charito Love; Hugh L Richardson; Samuel L Kipper; Frederick L Weiland; Maria B Tomas
Journal:  J Foot Ankle Surg       Date:  2003 Jan-Feb       Impact factor: 1.286

9.  Diagnosis of orthopedic infection in clinical practice using Tc-99m sulesomab (antigranulocyte monoclonal antibody fragment Fab'2).

Authors:  A Garcia Vicente; M Almoguera; J C Alonso; A Jimenez Heffernan; A Gomez; P I Contreras; J Martin-Comin
Journal:  Clin Nucl Med       Date:  2004-12       Impact factor: 7.794

Review 10.  Molecular Imaging of Diabetic Foot Infections: New Tools for Old Questions.

Authors:  Camilo A Ruiz-Bedoya; Oren Gordon; Filipa Mota; Sudhanshu Abhishek; Elizabeth W Tucker; Alvaro A Ordonez; Sanjay K Jain
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

View more
  2 in total

1.  What does the orthopaedic surgeon want in the radiology report?

Authors:  Karthikeyan P Iyengar; Vivien Qi Jun Ngo; Vijay Kumar Jain; Neeraj Ahuja; Zuned Hakim; Chetan Sangani
Journal:  J Clin Orthop Trauma       Date:  2021-07-24

2.  Magnetic Resonance Imaging Data Features to Evaluate the Efficacy of Compound Skin Graft for Diabetic Foot.

Authors:  Chunlei Wang; Xiaomei Yu; Ying Sui; Junhui Zhu; Bo Zhang; Yongtao Su
Journal:  Contrast Media Mol Imaging       Date:  2022-06-13       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.